Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

ClinicalTrials.gov ID: NCT00882258

Public ClinicalTrials.gov record NCT00882258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Selective Progesterone Receptor Modulator Proellex (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Study identification

NCT ID
NCT00882258
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Repros Therapeutics Inc.
Industry
Enrollment
144 participants

Conditions and interventions

Interventions

  • 12.5 mg Proellex Drug
  • 25 mg Proellex Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
Feb 28, 2007
Completion
Feb 28, 2007
Last update posted
Jul 7, 2014

2006 – 2007

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
Women's Health Research Phoenix Arizona 85015
Arizona Wellness Centre for Women Phoenix Arizona 85032
Visions Clinical Research Tuscon Tuscon Arizona 85712
Medical Centre for Clinical Research San Diego California 92108
Women's Health Care, Inc. San Diego California 92123
Downtown Women's Health Care Denver Colorado 80218
Visions Clinical Research Boynton Beach Florida 33437
Miami Research Associates, Women's Health Studies Miami Florida 33143
Insignia Clinical Research (Tampa Bay Women's Center) Tampa Florida 33607
Caring for Women Las Vegas Nevada 89106
Affiliated Clinical Research, Inc. Las Vegas Nevada 89128
SC Clinical Research Center Columbia South Carolina 29201
Advances in Health Inc. Houston Texas 77030
Obstetrical & Gynecolgical Associates, PA (OGA) Houston Texas 77054
Women's Clinical Research Centre Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00882258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00882258 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →